BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Saxocell - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Saxocell
X-ORIGINAL-URL:https://www.saxocell.de
X-WR-CALDESC:Veranstaltungen für Saxocell
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260401T020000
DTEND;TZID=Europe/Berlin:20260401T040000
DTSTAMP:20260520T070151
CREATED:20251215T103641Z
LAST-MODIFIED:20251215T103641Z
UID:16211-1775008800-1775016000@www.saxocell.de
SUMMARY:GeneNovate Workshop 4 part 1
DESCRIPTION:GeneNovate is the first nationwide entrepreneurship program in Germany designed to empower innovators and entrepreneurs in the fields of Gene and Cell Therapy\, Biotechnology\, and Medicine. \nThe program targets early-career scientists and physicians — including advanced students\, PhD candidates\, and postdocs — but is also open to experienced researchers and medical professionals. One of the program’s key strengths is its collaborative approach\, connecting participants across multiple institutions and locations. \nYou can find more information here. \nYou can also view our program flyer here. \n\nTopics to be discussed during this workshop include: \n\nTheoretical input for all Genovate trainees across all sites.\nHybrid session: onsite in Cologne and online
URL:https://www.saxocell.de/calendar/genenovate-workshop4-part1/
LOCATION:Leipzig University\, Augustuspl. 10\, Leipzig\, 04109
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260413T020000
DTEND;TZID=Europe/Berlin:20260413T040000
DTSTAMP:20260520T070151
CREATED:20251006T102434Z
LAST-MODIFIED:20251215T103536Z
UID:15761-1776045600-1776052800@www.saxocell.de
SUMMARY:GeneNovate Workshop 4 part 2
DESCRIPTION:GeneNovate is the first nationwide entrepreneurship program in Germany designed to empower innovators and entrepreneurs in the fields of Gene and Cell Therapy\, Biotechnology\, and Medicine. \nThe program targets early-career scientists and physicians — including advanced students\, PhD candidates\, and postdocs — but is also open to experienced researchers and medical professionals. One of the program’s key strengths is its collaborative approach\, connecting participants across multiple institutions and locations. \nYou can find more information here. \nYou can also view our program flyer here. \n\nTopics to be discussed during this workshop include: \n\nRegulation\nDevelop your product/solution\nGo-to-Market: Understand & win customers
URL:https://www.saxocell.de/calendar/genenovate-workshop4-part2/
LOCATION:Leipzig University\, Augustuspl. 10\, Leipzig\, 04109
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260413T060000
DTEND;TZID=Europe/Berlin:20260413T070000
DTSTAMP:20260520T070151
CREATED:20260326T081243Z
LAST-MODIFIED:20260326T081243Z
UID:16980-1776060000-1776063600@www.saxocell.de
SUMMARY:CTGCT Science Talk Webinar: Programmable T Cell Therapies: From Precision Genome Editing to In Vivo Programming
DESCRIPTION:Programmable T Cell Therapies: From Precision Genome Editing to In Vivo Programming.  \nDr. Thomas Fox is a clinician-scientist and Wellcome Trust Early Career Research Fellow working between the Dana-Farber Cancer Institute and Boston Children’s Hospital at Harvard Medical School and the UCL Institute of Immunity and Transplantation in London. His research focuses on developing next-generation genome engineering strategies to create safer and more effective immune cell therapies for cancer and inborn errors of immunity. His work combines CRISPR-based editing technologies with targeted delivery platforms such as lipid nanoparticles and virus-like particles to enable both ex vivo engineering and direct in vivo programming of T cells. In this talk\, he will discuss emerging strategies for building programmable Tcell therapies\, ranging from precision genome editing approaches to technologies that enable therapeutic T cells to be generated directly in patients\, with applications in cancer and immune dysregulation. \nYou can view the flyer here\, and you can join the webinar here.
URL:https://www.saxocell.de/calendar/ctgct-science-talk-webinar-programmable-t-cell-therapies-from-precision-genome-editing-to-in-vivo-programming/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260420T040000
DTEND;TZID=Europe/Berlin:20260420T043000
DTSTAMP:20260520T070151
CREATED:20260326T075632Z
LAST-MODIFIED:20260326T075632Z
UID:16972-1776657600-1776659400@www.saxocell.de
SUMMARY:SaxoCell Lunch Meeting with BIOTYPE
DESCRIPTION:On 20 April 2026\, from 12:00 to 12:30\, meet the newest member of SaxoCell e.V. – BIOTYPE GmbH! \nBIOTYPE is a family-run company based in Dresden which has specialised in the development and marketing of PCR-based test kits for over 25 years and focuses on personalised cancer diagnostics. From concept and development through to production\, regulatory affairs and marketing\, BIOTYPE brings together all the necessary expertise and uses this knowledge to support partners in research\, clinical practice and industry. \nBIOTYPE GmbH is an innovative solution provider for molecular precision diagnostics. They offer a robust portfolio of profiling assays\, alongside comprehensive CDMO services for the development and manufacturing of diagnostic tests. BIOTYPE guides clients from initial concept through sample testing to market-ready products. \nThe company develops and produces state‑of‑the‑art assays for the reliable detection of DNA and RNA biomarkers\, enabling personalized medicine and modern therapeutic strategies. \nSpeakers: \n\nSabine Kiessling-Parr (Business Development Managerin)\,\nDr. Manja Böhme (Chief Business Officer Custom Solutions)\,\nAlexandra Pissoke (Chief Business Officer Oncology)​​​​​​​\n\nWe are very excited to turn the spotlight over to BIOTYPE! \nIf you would like to join please fill out the form on this page.
URL:https://www.saxocell.de/calendar/saxocell-lunch-meeting-with-biotype/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260420
DTEND;VALUE=DATE:20260422
DTSTAMP:20260520T070151
CREATED:20260416T124622Z
LAST-MODIFIED:20260416T124708Z
UID:17768-1776700800-1776873599@www.saxocell.de
SUMMARY:German Biotech Days
DESCRIPTION:Germany’s Hotspot for Biotech Visionaries and Decision Makers \nThe German Biotech Days (DBT) bring together entrepreneurs with scientists and partners from politics\, investors\, funding institutions and administration.
URL:https://www.saxocell.de/calendar/german-biotech-days/
LOCATION:Kongresshalle Leipzig\, Pfaffendorfer Str. 31\, Leipzig\, Sachsen\, 04105
END:VEVENT
END:VCALENDAR